Tsumura & Co. · TSE:4540
Tsumura & — Q2 FY2015 Earnings Presentation
31 slides from Tsumura &'s earnings presentation, November 2014
Slide 1: ARRAS
ARRAS 6 sAoYOS 2015 3 2 2014 11 7
Slide 2: 2015 2012/00/00
2015 3 2 2 2012/00/00
Slide 3: 2Q 2Q 2Q
2015 3 2 2014 2014 2Q 2013 2Q 2Q 2Q 53,600 52,710 98.3% 53,398 687 1.3 7,600 8,585 113.0% 10,366 1,781 17.2 7,700 9,191 119.4% 10,965 1,774 16.2 4,800 6,128 127.7% 7,069 941 13.3 2014 2014 2013 2Q 2Q 2Q 14.2% 16.3% 19.4% 0.5% 32 32 32 1.9% (1 ) 2.3% 95.3% 3
Slide 4: + 2.1pt 3.1pt
98.3% 113% 52,710 1.7% 1.3% • 4 0.8% 98.3% • 9.38 8,585 +13.0% 17.2% 16.3% +2.1pt 3.1pt • 3.2pt 0.8pt • 3.6 11.2 1.3pt 9,191 +19.4% 16.2% • 14.9 19.4% 3.8 6,128 +27.7% 13.3% 4
Slide 5: Operating profit variance analysis
10,366 +251 938 1,453 +360 8,585 –938 129 +378 +239 –72 +181 –139 –570 2013 2Q 2014 2Q 5
Slide 6: 2Q 34.8 2Q 38.0 2Q 38.0
38.8 2014 2Q 38.0 0.8pt 2013 2Q 34.8 2014 2Q 38.0 3.2pt +1.4pt +1.2pt +0.6pt +3.2pt 6
Slide 7: 2014 B/S 2013 2Q 30 24 16 13 0 4 240 264 24 9
2014 B/S 2013 2Q 434 494 59 31 43 5 8 88 99 10 5 5 0 0 105 130 24 16 13 0 4 240 264 24 9 24 5 3 7
Slide 8: 2013 2014 2Q
126 149 6 13 18 0 53 20 229 144 150 2013 2014 2Q 8
Slide 9: 2006 2006 2007 008 2009 2010 2011 2012 2013 2014 9
241 234 244 2006 100 190 234 156 100 117 110 110 2006 2007 2008 2009 2010 2011 2012 2013 2014 9
Slide 10: 2012 2013 2014 2015 2016 2014 2016 2014 6 150 10
1 2 2012 2013 2014 2015 2016 5 1 10 1 3 2014 31 50 2016 2014 6 150 10
Slide 11: • • 31.5 % 28.4 % 25.0 % 38.3 % 31.6% 30.3% 22.3% 17.8%
• • 31.5 % 28.4 % 25.0 % 38.3 % 31.6% 30.3% 32 22.3% 32 17.8% 23 30 30 32 17 8.1% 9.1% 13 28 30 30 32 32 8 10 23 10 17 6 7 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 11
Slide 12: 2015 2012/00/00
2015 3 12 2012/00/00
Slide 13: Full-year forecast
2015 3 ( 2014 3 2015 3 110,057 111,400 1,342 1.2% 22,461 18,200 4,261 19.0% 23,966 18,400 5,566 23.2% 18,050 11,800 6,250 34.6% 2014 3 2015 3 20.4% 16.3% (1 ) 64 64 EPS 255.94 167.32 ROE 14.5% 8.8% 13
Slide 14: 2014 2012/00/00
2014 11 7 14 2012/00/00
Slide 15: IMS market data
2014 4–6 7–9 8–9 4–9 IMS 2.5% 0.0% 0.6% 1.3% IMS 1.3% 3.9% 5.3% 2.6% 3.8% 3.9% 4.7% 3.9% Copyright 2014 IMS IMS JPM 2013 4 –2014 9 15
Slide 16: etc.
2001 3 2011 3 1 8,000 5 5 1 etc. 16
Slide 17: 1. 2. 1,000 18,000 43% * 13,200 75% *2013 2014 9 17
1. 2. 5 129 5 650 1,000 18,000 285 43% * 13,200 75% *2013 4 2014 9 17
Slide 18: MR activities
2014 MR 6 42 9 7 10 9 13 14 15 11 12 14 17 15 18 17 2010 2011 2012 2013 2014 2014 3 5 42 6,000 907 MR 2014 18
Slide 19: 19
19
Slide 20: 20
20
Slide 21: 21
21
Slide 22: 1 27
1 27 45 127 22
Slide 23: 23
23
Slide 24: 24
24
Slide 25: • •
3 4 • • 25
Slide 26: EBM
10 10 & EBM 5 26
Slide 27: 1: | i on aa
10 . | i] . | 1: | i on aa a an of Jae a a a a ‘. i | a ‘. 7 ee | . i | i | . i | 1 | i on a8 age a jae a i} a 90% ea ee ee 10 10% 27
Slide 28: 2012/00/00
29 2012/00/00
Slide 29: 2014 2013 2Q 2Q 4,883 4,811 1.5% 3,534 3,551 0.5% 3 3,376 3,267 108
10 2014 2013 2Q 2Q 1 4,883 4,811 71 1.5% 2 3,534 3,551 16 0.5% 3 3,376 3,267 108 3.3% 4 3,247 3,258 10 0.3% 5 2,214 2,127 86 4.1% 6 2,053 2,126 72 3.4% 7 1,873 1,900 27 1.4% 8 1,768 1,733 35 2.0% 9 1,700 1,726 26 1.5% 10 1,322 1,212 109 9.0% 22 601 583 17 3.0% 129 50,236 49,857 378 0.8% 5 13,981 13,
Slide 30: Clinical study list
(DB-RCT & ) 30 Int J Cli Oncology 64 19 43 DDW2014 Gastric cancer JAPAN-PD Study 10 9 2015.3 DKB-14 Study 14 2014.8 2016.5 33 Psychopharmacology 2014.11 2016.10 BPSD 21 Journal of Gastroenterology (Online G-PRIDE Study 75 BioMed Central Gastroenterology FD DREAM Study 2014.4 2016.3 FD 2014.12 2016.3
Slide 31: TEL 03-6361-7101
TEL 03-6361-7101 • • •